Medical device having lithium-ion battery

ABSTRACT

A medical device includes a rechargeable lithium-ion battery for providing power to the medical device. The lithium-ion battery includes a positive electrode comprising a current collector and a first active material and a negative electrode comprising a current collector, a second active material, and a third active material. The first active material, second active material, and third active material are configured to allow doping and undoping of lithium ions. The third active material exhibits charging and discharging capacity below a corrosion potential of the current collector of the negative electrode and above a decomposition potential of the first active material.

BACKGROUND

The present invention relates generally to the field of lithium batteries. Specifically, the present invention relates to lithium-ion batteries that are relatively tolerant to over-discharge conditions and medical devices which utilize such batteries.

Lithium-ion batteries include a positive current collector (e.g., aluminum such as an aluminum foil) having an active material provided thereon (e.g., LiCoO₂) and a negative current collector (e.g., copper such as a copper foil) having an active material (e.g., a carbonaceous material such as graphite) provided thereon. Together the positive current collector and the active material provided thereon are referred to as a positive electrode, while the negative current collector and the active material provided thereon are referred to as a negative electrode.

FIG. 1 shows a schematic representation of a portion of a lithium-ion battery 10 such as that described above. The battery 10 includes a positive electrode 20 that includes a positive current collector 22 and a positive active material 24, a negative electrode 30 that includes a negative current collector 32 and a negative active material 34, an electrolyte material 40, and a separator (e.g., a polymeric microporous separator, not shown) provided intermediate or between the positive electrode 20 and the negative electrode 30. The electrodes 20, 30 may be provided as relatively flat or planar plates or may be wrapped or wound in a spiral or other configuration (e.g., an oval configuration). The electrode may also be provided in a folded configuration.

During charging and discharging of the battery 10, lithium ions move between the positive electrode 20 and the negative electrode 30. For example, when the battery 10 is discharged, lithium ions flow from the negative electrode 30 to the to the positive electrode 20. In contrast, when the battery 10 is charged, lithium ions flow from the positive electrode 20 to the negative electrode 30.

FIG. 2 is a graph 100 illustrating the theoretical charging and discharging behavior for a conventional lithium-ion battery. Curve 110 represents the electrode potential versus a lithium reference electrode for a positive electrode that includes an aluminum current collector having a LiCoO₂ active material provided thereon, while curve 120 represents the electrode potential versus a lithium reference electrode for a negative electrode that includes a copper current collector having a carbonaceous active material provided thereon. The difference between curves 110 and 120 is representative of the overall cell voltage.

As shown in FIG. 2, upon initial charging to full capacity, the potential of the positive electrode, as shown by curve 110, increases from approximately 3.0 volts to a point above the corrosion potential of copper used to form the negative electrode (designated by dashed line 122). The potential of the negative electrode decreases from approximately 3.0, volts to a point below the decomposition potential of the LiCoO₂ active material provided on the aluminum current collector (designated by dashed line 112). Upon initial charging, the battery experiences an irreversible loss of capacity due to the formation of a passive layer on the negative current collector, which may be referred to as a solid-electrolyte interface (“SEI”). The irreversible loss of capacity is shown as a ledge or shelf 124 in curve 120.

One difficulty with conventional lithium-ion batteries is that when such a battery is discharged to a point near zero volts, it may exhibit a loss of deliverable capacity and corrosion of the negative electrode current collector (copper) and possibly of the battery case, depending on the material used and the polarity of the case. As shown in FIG. 2, after initial charging of the battery, a subsequent discharge of the battery in which the voltage of the battery approaches zero volts (i.e., zero percent capacity) results in a negative electrode potential that follows a path designated by dashed line 126. As shown in FIG. 2, the negative electrode potential levels off or plateaus at the copper corrosion potential of the negative current collector (approximately 3.5 volts for copper and designated by dashed line 122 in FIG. 2).

The point at which the curves 110 and 120 cross is sometimes referred to as the zero voltage crossing potential, and corresponds to a cell voltage that is equal to zero (i.e., the difference between the two curves equals zero at this point). Because of the degradation of the copper current collector which occurs at the copper corrosion potential, the copper material used for the negative current collector corrodes before the cell reaches a zero voltage condition, resulting in a battery that exhibits a dramatic loss of deliverable capacity.

While FIG. 2 shows the theoretical charging and discharging behavior of a battery that may experience corrosion of the negative current collector when the battery approaches a zero voltage configuration, it should be noted that there may also be cases in which the active material on the positive current collector may degrade in near-zero-voltage conditions. In such cases, the theoretical potential of the positive electrode versus a lithium reference electrode would decrease to the decomposition potential of the positive active material (shown as line 112 in FIG. 2), at which point the positive active material would decompose, resulting in potentially decreased protection against future over-discharge conditions.

Because damage to the lithium-ion battery may occur in the event of a low voltage condition, conventional lithium-ion batteries may include protection circuitry and/or may be utilized in devices that include protection circuitry which substantially reduces the current drain from the battery (e.g., by disconnecting the battery).

The medical device industry produces a wide variety of electronic and mechanical devices for treating patient medical conditions. Depending upon the medical condition, medical devices can be surgically implanted or connected externally to the patient receiving treatment. Clinicians use medical devices alone or in combination with drug therapies and surgery to treat patient medical conditions. For some medical conditions, medical devices provide the best, and sometimes the only, therapy to restore an individual to a more healthful condition and a fuller life.

It may be desirable to provide a source of battery power for such medical devices, including implantable medical devices. In such cases, it may be advantageous to provide a battery that may be recharged. It may also be advantageous to provide a battery that may be discharged to a near zero voltage condition without substantial risk that the battery may be damaged (e.g., without corroding one of the electrodes or the battery case, decomposing the positive active material, etc.) such that the performance of the battery is degraded in subsequent charging and discharging operations.

It would be advantageous to provide a battery (e.g., a lithium-ion battery) that may be discharged to near zero volts without producing a subsequent decrease in the amount of deliverable capacity or producing a corroded negative electrode or battery case. It would also be advantageous to provide a battery that compensates for the irreversible loss of capacity resulting from initial charging of the battery to allow the battery to be used in near zero voltage conditions without significant degradation to battery performance. It would also be advantageous to provide a medical device (e.g., an implantable medical device) that utilizes a battery that includes any one or more of these or other advantageous features.

SUMMARY

An exemplary embodiment relates to a medical device that includes a rechargeable lithium-ion battery for providing power to the medical device. The lithium-ion battery includes a positive electrode comprising a current collector and a first active material and a negative electrode comprising a current collector, a second active material, and a third active material. The first active material, second active material, and third active material are configured to allow doping and undoping of lithium ions. The third active material exhibits charging and discharging capacity below a corrosion potential of the current collector of the negative electrode and above a decomposition potential of the first active material.

Another exemplary embodiment relates to a device for providing a therapeutic treatment to a patient. The device includes a rechargeable battery for providing power for the device. The battery includes a positive current collector and a negative current collector. An active material is provided on the positive current collector, and an active material layer is provided on the negative current collector. The active material layer includes a primary active material and a secondary active material, the secondary active material exhibiting charge and discharge capacity below a corrosion potential of the negative current collector. The secondary active material does not include lithium. A mass of lithium is provided in electrical contact with a portion of the negative current collector.

Another exemplary embodiment relates to a system for providing a medical treatment to a patient. The system includes a lithium-ion battery configured to provide power to the system and capable of being charged and discharged. The lithium-ion battery includes a positive electrode comprising a positive current collector and an active material provided on at least one side of the positive current collector. The lithium-ion battery also includes a negative electrode having a negative current collector and a primary active material and an auxiliary active material provided on at least one side of the negative current collector. The auxiliary active material includes lithium and provides charging and discharging capacity for the positive electrode below a corrosion potential of the negative current collector and above a decomposition potential of the active material provided on the positive current collector.

Another exemplary embodiment relates to a method of treating a medical condition of a patient. The method includes providing at least a portion of a medical device in contact with the patient and providing a treatment to the patient utilizing the medical device. The medical device receives power from a battery that includes a positive electrode comprising a current collector and a first active material and a negative electrode comprising a current collector, a second active material, and a third active material. The first active material, second active material, and third active material are configured to allow doping and undoping of lithium ions. The third active material exhibits charging and discharging capacity below a corrosion potential of the current collector of the negative electrode and above a decomposition potential of the first active material.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a schematic cross-sectional view of a conventional lithium-ion battery.

FIG. 2 is a graph illustrating the theoretical charging and discharging behavior for a conventional lithium-ion battery such as that shown schematically in FIG. 1.

FIG. 3 is a schematic cross-sectional view of a portion of a lithium-ion battery according to an exemplary embodiment.

FIG. 4 is a schematic cross-sectional view of a portion of a lithium-ion battery according to another exemplary embodiment.

FIG. 5 is a graph illustrating the theoretical charging and discharging behavior for a lithium-ion battery such as that shown in FIG. 3.

FIG. 6 is a schematic view of a system in the form of an implantable medical device implanted within a body or torso of a patient.

FIG. 7 is schematic view of another system in the form of an implantable medical device.

DETAILED DESCRIPTION OF THE EXEMPLARY EMBODIMENTS

With reference to FIG. 3, a schematic cross-sectional view of a portion of a lithium-ion battery 200 is shown according to an exemplary embodiment. According to an exemplary embodiment, the battery 200 has a rating of between approximately 10 and 1000 milliampere hours (mAh). According to another exemplary embodiment, the battery has a rating of between approximately 100 and 400 mAh. According to another exemplary embodiment, the battery is an approximately 300 mAh battery. According to another exemplary embodiment, the battery is an approximately 75 mAh battery.

The battery 200 includes at least one positive electrode 210 and at least one negative electrode 220. The electrodes may be provided as flat or planar components of the battery 200, may be wound in a spiral or other configuration, or may be provided in a folded configuration. For example, the electrodes may be wrapped around a relatively rectangular mandrel such that they form an oval wound coil for insertion into a relatively prismatic battery case. According to other exemplary embodiments, the battery may be provided as a button cell battery, a thin film solid state battery, or as another lithium-ion battery configuration.

The battery case (not shown) may be made of stainless steel or another metal. According to an exemplary embodiment, the battery case may be made of titanium, aluminum, or alloys thereof. According to another exemplary embodiment, the battery case may be made of a plastic material or a plastic-foil laminate material (e.g., an aluminum foil provided intermediate a polyolefin layer and a polyester layer).

According to an exemplary embodiment, the negative electrode is coupled to a stainless steel case by a member or tab comprising nickel or a nickel alloy. An aluminum or aluminum alloy member or tab may be coupled or attached to the positive electrode. The nickel and aluminum tabs may serve as terminals for the battery according to an exemplary embodiment.

The dimensions of the battery 200 may differ according to a variety of exemplary embodiments. For example, according to one exemplary embodiment in which the electrodes are wound such that they may be provided in a relatively prismatic battery case, the battery has dimensions of between approximately 30-40 mm by between approximately 20-30 mm by between approximately 5-7 mm. According to another exemplary embodiment, the dimensions of the battery are approximately 20 mm by 20 mm by 3 mm. According to another exemplary embodiment, a battery may be provided in the form of a button cell type battery having a diameter of approximately 30 mm and a thickness of approximately 3 mm. It will be appreciated by those of skill in the art that such dimensions and configurations as are described herein are illustrative only, and that batteries in a wide variety of sizes, shapes, and configurations may be produced in accordance with the novel concepts described herein.

An electrolyte 230 is provided intermediate or between the positive and negative electrodes to provide a medium through which lithium ions may travel. According to an exemplary embodiment, the electrolyte may be a liquid (e.g., a lithium salt dissolved in one or more non-aqueous solvents). According to another exemplary embodiment, the electrolyte may be a lithium salt dissolved in a polymeric material such as poly(ethylene oxide) or silicone. According to another exemplary embodiment, the electrolyte may be an ionic liquid such as N-methyl-N-alkylpyrrolidinium bis(trifluoromethanesulfonyl)imide salts. According to another exemplary embodiment, the electrolyte may be a solid state electrolyte such as a lithium-ion conducting glass such as lithium phosphorous oxynitride (LiPON).

Various other electrolytes may be used according to other exemplary embodiments. For example, according to an exemplary embodiment, the electrolyte may be a 1:1 mixture of ethylene carbonate to diethylene carbonate (EC:DEC) in a 1.0 M salt of LiPF₆. According to another exemplary embodiment, the electrolyte may include a polypropylene carbonate solvent and a lithium bis-oxalatoborate salt (sometimes referred to as LiBOB). According to other exemplary embodiments, the electrolyte may comprise one or more of a PVDF copolymer, a PVDF-polyimide material, and organosilicon polymer, a thermal polymerization gel, a radiation cured acrylate, a particulate with polymer gel, an inorganic gel polymer electrolyte, an inorganic gel-polymer electrolyte, a PVDF gel, polyethylene oxide (PEO), a glass ceramic electrolyte, phosphate glasses, lithium conducting glasses, lithium conducting ceramics, and an inorganic ionic liquid or gel, among others.

A separator 250 is provided intermediate or between the positive electrode 210 and the negative electrode 220. According to an exemplary embodiment, the separator 250 is a polymeric material such as a polypropylene/polyethelene or another polyolefin multilayer laminate that includes micropores formed therein to allow electrolyte and lithium ions to flow from one side of the separator to the other. The thickness of the separator 250 is between approximately 10 micrometers (μm) and 50 μm according to an exemplary embodiment. According to a particular exemplary embodiment, the thickness of the separator is approximately 25 μm and the average pore size of the separator is between approximately 0.02 μm and 0.1 μm.

The positive electrode 210 includes a current collector 212 made of a conductive material such as a metal. According to an exemplary embodiment, the current collector 212 comprises aluminum or an aluminum alloy. According to an exemplary embodiment, the thickness of the current collector 212 is between approximately 5 μm and 75 μm. According to a particular exemplary embodiment, the thickness of the current collector 212 is approximately 20 μm. It should also be noted that while the positive current collector 212 has been illustrated and described as being a thin foil material, the positive current collector may have any of a variety of other configurations according to various exemplary embodiments. For example, the positive current collector may be a grid such as a mesh grid, an expanded metal grid, a photochemically etched grid, or the like.

The current collector 212 has a layer of active material 214 provided thereon (e.g., coated on the current collector). While FIG. 3 shows that the active material 214 is provided on only one side of the current collector 212, it should be understood that a layer of active material similar or identical to that shown as active material 214 may be provided or coated on both sides of the current collector 212.

According to an exemplary embodiment, the active material 214 is a material or compound that includes lithium. The lithium included in the active material 214 may be doped and undoped during discharging and charging of the battery, respectively. According to an exemplary embodiment, the active material 214 is lithium cobalt oxide (LiCoO₂). According to another exemplary embodiment, the positive active material is of the form LiCo_(x)Ni_((1-x))O₂, with x being between approximately 0.05 and 0.8. According to another exemplary embodiment, the primary active material is of the form LiAl_(x)Co_(y)Ni_((1−x−y))O₂, where x is between approximately 0.05 and 0.3 and y is between approximately 0.1 and 0.3. According to other exemplary embodiments, the primary active material may include LiMn₂O₄.

According to various other exemplary embodiments, the active material provided on the current collector 212 may include a material such as a material of the form Li_(1−x)MO₂ where M is a metal (e.g., LiCoO₂, LiNiO₂, and LiMnO₂), a material of the form Li_(1−w)(M′_(x)M″_(y))O₂ where M′ and M″ are different metals (e.g., Li(Ni_(x)Mn_(y))O₂, Li(Ni_(1/2)Mn_(1/2))O₂, Li(Cr_(x)Mn_(1−x))O₂, Li(Al_(x)Mn_(1−x))O₂, Li(Co_(x)M_(1−x))O₂, Li(Co_(x)Ni_(1−x))O₂, and Li(Co_(x)Fe_(1−x))O₂)), a material of the form Li_(1−w)(Mn_(x)Ni_(y)Co_(z))O₂ (e.g., LiCo_(x)Mn_(y)Ni_((1−x−y))O₂, Li(Mn_(1/3)Ni_(1/3)Co_(1/3))O₂, Li(Mn_(1/3)Ni_(1/3)Co_(1/3−x)Mg_(x))O₂, Li(Mn_(0.4)Ni_(0.4)CO_(0.2))O₂, and Li(Mn_(0.1)Ni_(0.1)Co_(0.8))O₂), a material of the form Li_(1−w)(Mn_(x)Ni_(x)Co_(1−2x))O₂, a material of the form Li_(1−w)(Mn_(x)Ni_(y)Co_(z)Al_(w))O₂, a material of the form Li_(1−w)(Ni_(x)Co_(Y)Al_(z))O₂ (e.g., Li(Ni_(0.8)Co_(0.05)Al_(0.05))O₂), a material of the form Li_(1−w)(Ni_(x)Co_(Y)M_(z))O₂, where M is a metal, a material of the form Li_(1−w)(Ni_(x)Mn_(y)M_(z))O₂, where M is a metal, a material of the form Li(Ni_(x−y)Mn_(y)Cr_(2−x))O₄, LiMn₂O₄, a material of the form LiM′M″₂O₄ where M′ and M″ are different metals (e.g., LiMn_(2−y−z)Ni_(y), Li_(z)O₄, LiMn_(1.5)Ni_(0.5)O₄, LiNiCuO₄, LiMn_(1−x)Al_(x)O₄, LiNi_(0.5)Ti_(0.5)O₄, and Li_(1.05)Al_(0.1)Mn_(1.85)O₄F_(z)), Li₂MnO₃, a material of the form Li_(x)V_(y)O_(z) (e.g., LiV₃O₈, LiV₂O₅, and LiV₆O₁₃), a material of the form LiMPO₄ where M is a metal or LiM_(x)′M″_(1−x)PO₄ where M′ and M″ are different metals (e.g., LiFePO₄, LiFe_(x)M_(1−x)PO₄, LiVOPO₄, and Li₃V₂(PO₄)₃), and LIMPO_(4x) where M is a metal such as iron or vanadium and x is a halogen such as fluorine, and combinations thereof.

A binder material may also be utilized in conjunction with the active material 214. For example, according to an exemplary embodiment, the active material may include a conductive additive such as carbon black and a binder such as polyvinylidine fluoride (PVDF) or an elastomeric polymer.

According to an exemplary embodiment, the thickness of the active material 214 is between approximately 0.1 μm and 3 mm. According to a particular exemplary embodiment, the thickness of the active material 214 is between approximately 25 μm and 300 μm. According to a particular exemplary embodiment, the thickness of the layer of active material 214 is approximately 75 μm.

The negative electrode 220 includes a current collector 222 that is made of a conductive material such as a metal. According to an exemplary embodiment, the current collector 222 is copper or a copper alloy. According to another exemplary embodiment, the current collector 222 may be titanium or a titanium alloy. According to another exemplary embodiment, the current collector 222 is nickel or a nickel alloy. According to another exemplary embodiment in which the negative active material 224 is not carbon, the current collector 222 is aluminum or an aluminum alloy. It should also be noted that while the negative current collector 222 has been illustrated and described as being a thin foil material, the positive current collector may have any of a variety of other configurations according to various exemplary embodiments. For example, the positive current collector may be a grid such as a mesh grid, an expanded metal grid, a photochemically etched grid, or the like.

According to an exemplary embodiment, the thickness of the current collector 222 is between approximately 100 nm and 100 μm. According to a particular exemplary embodiment, the thickness of the current collector 222 is between approximately 5 μm and 25 μm. According to a particular exemplary embodiment, the thickness of the current collector is approximately 10 μm.

The negative current collector 222 has a layer of active material 224 provided thereon. While FIG. 3 shows that the active material 224 is provided on only one side of the current collector 222, it should be understood that a layer of active material similar or identical to that shown may be provided or coated on both sides of the current collector 222.

Layer 224 includes a primary active material 226 and a secondary or auxiliary active material 228. While the primary active material 226 and the secondary active material 228 are shown as being provided as a single layer of material in FIG. 3, it will be appreciated that the primary active material 226 and the secondary active material 228 may be provided as separate individual layers (see, e.g., FIG. 4). A binder material and/or a solvent (not shown) may also be utilized in conjunction with the active material 224. For example, according to an exemplary embodiment, the active material may include a conductive additive such as carbon black and a binder such as polyvinylidine fluoride (PVDF) or an elastomeric polymer.

According to exemplary embodiment, the primary active material 226 is a carbonaceous material (e.g., carbon such as graphite). According to another exemplary embodiment, the primary active material 226 is a lithium titanate material such as Li₄Ti₅O₁₂. One advantage of using a lithium titanate material in place of a carbonaceous material is that it is believed that the use of a lithium titanate material allows for charging and discharging of the battery at higher rates than is capable using carbonaceous materials.

Other lithium titanate materials which may be suitable for use as the negative active material may include one or more of include the following lithium titanate spine1 materials: H_(x)Li_(y−x)TiO_(x)O₄H_(x)Li_(y−x)TiO_(x)O₄, Li₄M_(x)Ti_(5−x)O₁₂, Li_(x)Ti_(y)O₄, Li_(x)Ti_(y)O₄, Li₄[Ti_(1.67)Li_(0.33−y)M_(y)]O₄, Li₂TiO₃, Li₄Ti_(4.75)V_(0.25)O₁₂, Li₄Ti_(4.75)Fe_(0.25)O_(11.88), and Li₄Ti_(4.5)Mn_(0.5)O₁₂, and LiM′M″XO₄ (where M′ is a metal such as nickel, cobalt, iron, manganese, vanadium, copper, chromium, molybdenum, niobium, or combinations thereof), M″ is an optional three valent non-transition metal, and X is zirconium, titanium, or a combination of these two. Note that such lithium titanate spine1 materials may be used in any state of lithiation (e.g., Li_(4+x)Ti₅O₁₂, where 0≦x≦3).

One advantage of using a lithium titanate material instead of a carbonaceous material is that it is believed that the use of a lithium titanate material allows for charging and discharging of the battery at higher rates than is capable using carbonaceous materials. According to other exemplary embodiments, the negative active material 224 may be carbon, Li_(x)Al, Li_(x)Sn, Li_(x)Si, Li_(x)SnO, metal nanoparticle composites (e.g., including Li_(x)Al, Li_(x)Sn, Li_(x)Si, or Li_(x)SnO), or carbon-coated lithium titanate. Lithium titanate materials are also believed to offer superior cycle life because they are so called “zero-strain” materials. Zero strain materials have crystal lattices which do not experience shrinkage or contraction with lithium doping/de-doping, making them free from strain-related degradation mechanisms.

Another advantageous feature of using a lithium titanate material is that it is believed that when used in a negative electrode of a lithium-ion battery, such materials will cycle lithium at a potential plateau of about 1.5 V versus a lithium reference electrode. This is substantially higher than graphitic carbon, which is traditionally used in lithium ion batteries, and cycles lithium down to about 0.1 V in the fully charged state. As a result, the battery using lithium titanate is believed to be less likely to result in plating of lithium (which occurs at 0 V versus a lithium reference) while being charged. Lithium plating is a well-known phenomenon that can lead to loss in performance of lithium ion batteries. Being free from the risk lithium plating, cells with lithium titanate negative electrodes may also be charged at rates that exceed those with carbon negative electrodes. For example, a common upper limit for the rate of charge in lithium ion batteries is about 1 C (meaning that the battery can be fully charged from the discharged state in one hour). Conversely, it has been reported in literature that lithium titanate may be charged at rates up to 10 C (i.e., attaining full charge in 1/10 hour, or six minutes). Being able to recharge a battery more quickly substantially increases the functionality of devices that employ such a battery. A further advantage of the higher potential of the lithium titanate material is that it avoids decomposition of organic solvents (such as propylene carbonate) commonly used in lithium ion batteries. In so doing, it may reduce negative consequences such as formation of gas, cell swelling, and reduction of reversible battery capacity.

The secondary active material 228 is a material that is selected to have relatively significant charge and discharge capacity below the corrosion potential of the material used for a negative current collector 222 provided as part of the negative electrode 220 and above the decomposition potential of the active material 214 provided on the positive current collector 212. The secondary active material is also selected to be stable over its full potential-composition range in the electrolyte. For example, according to an exemplary embodiment in which the negative current collector 222 comprises copper, for which the corrosion potential is approximately 3.5 volts, the secondary active material 228 includes significant charge and discharge capacity below 3.5 volts.

The secondary active material 228 may or may not contain lithium. According to an exemplary embodiment in which the secondary active material does not include lithium, the secondary active material is V₆O₁₃. According to another exemplary embodiment in which the secondary active material includes lithium, the secondary active material is LiMn₂O₄. According to various other exemplary embodiments, the secondary active material may be selected from the following materials and combinations thereof: V₂O₅, V₆O₁₃, LiMn₂O₄ (spine1), LiM_(x)Mn_(2−x))O₄ (spine1) where M is metal (including Li) and x is between approximately 0.05 and 0.4, Li₅Ti₄O₁₂, Li_(x)VO₂ (where x is between approximately 0 and 1), V₃O₈, MoO₃, TiS₂, WO₂, MoO₂, and RuO₂, as well as their partially or fully lithiated counterparts.

Any lithium included in the secondary active material 228 of the negative electrode has significant charge/discharge capacity that lies below the corrosion potential of the negative current collector and/or any battery components to which it is electrically connected (e.g., the case) and above the decomposition potential of the positive electrode active material. The secondary active material contains electrochemically active lithium in the as constructed state. The lithium becomes significantly doped at a potential below the corrosion potential for the negative current collector 222. In so doing, this material lowers the final potential of the positive electrode in the discharge state, so that the zero voltage crossing potential remains below the corrosion potential of the negative current collector and the battery case. The secondary active material may be capable of releasing the lithium when the battery is charged.

It should be noted that while a variety of materials have been described above as being useful for secondary active material 228, a variety of additional materials may be utilized in addition to or in place of such materials. For example, the secondary active material may comprise an oxide material such as one or more of Li_(x)MoO₃ (0<x≦2), Li_(x)MoO₂ (0<x≦1), Li_(x)Mo₂O₄ (0<x≦2), Li_(x)MnO₂ (0<x≦1), Li_(x)Mn₂O₄ (0<x≦2), Li_(x)V₂O₅ (0<x≦2.5), Li_(x)V₃O₈ (0<x≦3.5), Li_(x)V₆O₁₃ (0<x≦6 for Li_(x)VO_(2.19) and 0<x≦3.6 for Li_(x)VO_(2.17)), Li_(x)VO₂ (0<x≦1), Li_(x)WO₃ (0<x≦1), Li_(x)WO₂ (0<x≦1), Li_(x)TiO₂ (anatase) (0<x≦1), Li_(x)Ti₂O₄ (0<x≦2), Li_(x)RuO₂ (0<x≦1), Li_(x)Fe₂O₃ (0<x≦2), Li_(x)Fe₃O₄ (0<x≦2), Li_(x)Cr₂O (0<x≦3), Li_(x)Cr (0<x≦3.8), Li_(x)Ni_(y)Co_(1−y)O₂ (0<x≦1, 0.90<y≦1.00), where x is selected such that these materials have little or no lithium that becomes undoped below the corrosion potential of the negative current collector during the first charge of the battery.

According to another exemplary embodiment, the secondary active material may comprise a sulfide material such as one or more of Li_(x)V₂S₅ (0<x≦4.8), Li_(x)TaS₂ (0<x≦1), Li_(x)FeS (0<x≦1), Li_(x)FeS₂ (0<x≦1), Li_(x)NbS₃ (0<x≦2.4), Li_(x)MoS₃ (0<x≦3), Li_(x)MoS₂ (0<x≦1), Li_(x)TiS₂ (0<x≦1), Li_(x)ZrS₂ (0<x≦1), Li_(x)Fe_(00.25) V₀₇₅S₂ (0<x≦1), Li_(x)Cr_(0.75)V_(0.25)S₂ (0<x≦0.65), Li_(x)Cr_(0.5)V_(0.5)S₂ (0<x≦1) where x is selected such that these materials have little or no lithium that becomes undoped below the corrosion potential of the negative current collector during the first charge of the battery.

According to another exemplary embodiment, the secondary active material may comprise a selenide material such as one or more of Li_(x)NbSe₃ (0<x≦3), Li_(x)VSe₂ (0<x≦1). Various other materials may also be used, for example, Li_(x)NiPS₃ (0<x≦1.5) and Li_(x)FePS₃ (0<x≦1.5) where x is selected such that these materials have little or no lithium that becomes undoped below the corrosion potential of the negative current collector during the first charge of the battery.

According to an exemplary embodiment in which the secondary active material 228 does not include lithium in the as constructed state (e.g., the secondary active material is V₆O₁₃), a mechanism is provided to lithiate the secondary active material 228. According to an exemplary embodiment, a mass or quantity of lithium (e.g., a lithium “patch”) may be provided, as will be discussed in greater detail below.

According to various exemplary embodiments, the thickness of the active material 224 is between approximately 0.1 μm and 3 mm. According to other exemplary embodiments, the thickness of the layer of active material 224 may be between approximately 25 μm and 300 μm. According to a particular exemplary embodiment, the thickness of the active material 224 is approximately 75 μm. In embodiments in which the primary active material 226 and the secondary active material 228 are provided as separate layers of active material, the thickness of the primary active material 226 is between approximately 25 μm and 300 μm (and approximately 75 μm according to a particular exemplary embodiment), while the thickness of the secondary active material 218 is between approximately 5 μm and 60 μm (and approximately 10 μm according to a particular exemplary embodiment).

As shown in FIG. 3, a mass or quantity of electrochemically active lithium (shown as a piece of lithium in the form of a lithium patch or member 240) is shown as being coupled or attached to the negative current collector 222. Such a configuration corresponds to a situation in which the secondary active material 228 is provided without including electrochemically active lithium (e.g., the secondary active material 228 does not include lithium as it is coated on the negative current collector). One such exemplary embodiment involves the use of V₆O₁₃ for the secondary active material. In contrast, FIG. 4 shows a configuration in which the secondary active material 228 is provided as a lithiated material (e.g., LiMn₂O₄). In such an embodiment, a lithium patch is not necessary.

The electrochemically active lithium may be provided in other locations in the negative electrode 220 and/or may have a different size or shape than that shown schematically in FIG. 3. For example, the electrochemically active lithium may be provided as a disc or as a rectangular piece of material coupled to the negative current collector. While the electrochemically active lithium is shown as being provided on a single side of the current collector 222 in FIG. 3 (e.g., as a lithium patch), separate lithium patches may be provided on opposite sides of the current collector 222. Further, multiple lithium patches may be provided on one or more of the sides of the current collector 222. In another example, the lithium may be provided elsewhere within the battery and connected (e.g., by a wire) to the current collector 222.

The electrochemically active lithium may be added through a chemical or electrochemical process. Such processes could include the addition of butyl lithium or electrical contact with metallic lithium or any other lithium source containing lithium and having an electrochemical potential lower than that of the secondary material (and optionally adding an electrolyte to activate the process). According to another exemplary embodiment, the process may be an electrolytic process, in which the precursor secondary material is polarized to a cathodic potential at which lithium ions present in an electrolyte are inserted into the precursor material. It should also be noted that electrochemically cyclable lithium may be added by adding lithium-containing compounds such as a lithium intermetallic compound such as a lithium-aluminum compound, a lithium-tin compound, a lithium-silicon compound, or any other similar compound that irreversibly donates lithium at a potential below that of the corrosion potential of the negative current collector (and any material to which it is electrically connected).

According to another exemplary embodiment, the electrochemically active or cyclable lithium may be added as finely divided or powdered lithium. Such powdered lithium may include a passive coating (e.g., a thin layer or film of lithium carbonate) provided thereon to reduce the reactivity of the powdered lithium with air and moisture. Such material may be mixed with the negative electrode active material prior to application of the negative electrode active material to fabrication of the cells or may be added as another separate active material layer. According to an exemplary embodiment, the finely divided or powdered lithium particles have a diameter of between approximately 1 μm and 100 μm, and according to a particular embodiment, between approximately 5 μm and 30 μm.

One advantage of providing electrochemically active lithium at the negative electrode (e.g., in the form of one or more lithium patches) is that the secondary active material 228 may be partially or completely lithiated by the lithium to compensate for the irreversible loss of capacity which occurs upon the first charging of the battery 200. For example, when the battery cell is filled with electrolyte, lithium from the lithium patch 240 is oxidized and inserted into the negative active material (i.e., the lithium in the electrochemically active lithium is effectively “shorted” to the negative active material).

The electrochemically active lithium may also provide a number of additional advantages. For example, it may act to maintain the potential of the negative current collector below its corrosion potential prior to initial charging (“formation”) of the battery. The electrochemically active lithium may also aid in the formation of the solid-electrolyte interface (“SEI”) at the negative electrode. Further, the electrochemically active lithium may provide the “formation” of the active material on the negative electrode without a corresponding reduction in battery capacity as would occur when the source of lithium for formation is the active material from the positive electrode.

The amount of electrochemically active lithium is selected such the amount of electrochemical equivalents provided by the electrochemically active lithium at minimum corresponds to the irreversible capacity of the negative electrode active material and at maximum corresponds to the sum of the irreversible capacity of the negative electrode active material and the capacity of the secondary active material 228. In this manner, the electrochemically active lithium at least compensates for the irreversible loss of capacity which occurs on initial charging of the battery 200 and most preferably corresponds to the sum of the irreversible capacity of the negative electrode active material and the capacity of the secondary active material 228.

According to an exemplary embodiment in which a lithium patch 240 is utilized, the size of the lithium patch 240 is between approximately 1.4 cm×1.4 cm×0.11 cm, which corresponds to approximately 0.013 grams (e.g., approximately 50 mAh). The specific size of the lithium patch may vary according to other exemplary embodiments (e.g., approximately 5-25 percent of the capacity of either the negative or positive electrode).

FIG. 5 is a graph 300 illustrating the theoretical charging and discharging behavior for a lithium-ion battery constructed in accordance with an exemplary embodiment such as that shown and described with regard to FIG. 3. Curve 310 represents the electrode potential versus a lithium reference electrode for a positive electrode (e.g., positive electrode 210) that includes an aluminum current collector having a LiCoO₂ primary active material provided thereon.

Curve 320 represents the electrode potential versus a lithium reference electrode for a negative electrode that includes a copper current collector having a primary active material (i.e., a carbonaceous material such as carbon), a non-lithiated secondary active material, and a lithium patch provided thereon. The difference between curves 310 and 320 is representative of the overall cell voltage of the battery.

The secondary active material is selected to provide significant charging/discharging capacity below the corrosion potential (shown as dashed line 322) of the negative current collector and above the decomposition potential (shown as dashed line 312) of the LiCoO₂ positive electrode active material, in addition to its ability to remain stable over its full potential-composition range in the electrolyte. According to an exemplary embodiment, the secondary active material is V₆O₁₃. According to various other exemplary embodiments, the secondary active material may be selected from the following materials and combinations thereof: V₂O₅, V₆O₁₃, V₃O₈, MoO₃, TiS₂, WO₂, MoO₂, and RuO₂.

It should be noted that the theoretical charging and discharge behavior for the negative electrode is believed to be qualitatively similar to that shown in FIG. 5 for a copper current collector having a Li₄Ti₅O₁₂ primary active material provided thereon (as opposed to a carbon active material), with the relatively flat portion of the curve 320 being shifted upward to a level of approximately 1.57 volts (in contrast to the approximately 0.1 volts for the carbon active material).

As shown in FIG. 5, upon initial charging to full capacity, the potential of the positive electrode, as shown by curve 310, increases from approximately 3.0 volts (shown as point 311) to a point above the corrosion potential of copper used to form the negative current collector (designated by dashed line 322). When the battery is subsequently discharged toward a zero voltage condition, the positive electrode potential will continue along a portion 314 of curve 310 to a point below approximately 3.0 volts (as shown by the dashed portion of curve 310 in FIG. 5).

The potential of the negative electrode decreases from approximately 3.0 volts on initial charging to a point below the decomposition potential of the LiCoO₂ active material provided on the positive current collector (designated by dashed line 312). According to an exemplary embodiment, the corrosion potential of copper is approximately 3.5 volts, while the decomposition potential of the LiCoO₂ active material provided on the positive current collector is approximately 1.6 volts. According to another exemplary embodiment, the decomposition potential of the LiCoO₂ active material is approximately 1.35 volts.

The initial capacity of the negative electrode is provided by the secondary active material (e.g., V₆O₁₃), as illustrated by the portion of the graph 300 designated by arrow 328. After the capacity of the secondary active material is exhausted, the battery experiences an irreversible loss of capacity due to the formation of a passive layer on the negative electrode, which may be referred to as a solid-electrolyte interface (“SEI”). The irreversible loss of capacity is shown as a ledge or shelf 324 in curve 320. The lithium patch is provided so as to compensate for the irreversible loss of capacity, and may be provided such that it compensates both for the initial capacity of the secondary active material (e.g., arrow 328) and the irreversible loss of capacity (ledge 324).

Upon discharging the battery to a point approaching zero volts, the negative electrode potential follows a path designated by a dashed portion 326 of the curve 320. However, because the secondary active material is chosen to have significant charging/discharging capacity below the corrosion potential of the negative current collector and above the decomposition potential of the LiCoO₂ primary active material, the zero voltage crossing potential (shown as point 330) is below the corrosion potential of the negative current collector and above the decomposition potential of the LiCoO₂ primary active material, thus avoiding corrosion of the negative current collector (and potentially of the battery case or any other battery component in electrical contact or communication with the negative electrode) and any associated loss of battery charging capacity. One advantageous feature of such an arrangement is that the battery may be repeatedly cycled (i.e., charged and discharged) to near-zero-voltage conditions without significant decline in battery performance.

It is intended that a lithium-ion battery such as that described herein may be fully discharged while the materials for both electrodes, including their corresponding current collectors, are stable (e.g., corrosion of the current collectors and/or the decomposition of active material may be avoided, etc.). One potential advantageous feature of such an arrangement is that the occurrence of reduced device functionality (i.e., the need to recharge more frequently) and corrosion of the current collectors and battery case (with the incumbent possibility of leaking potentially corrosive and toxic battery contents) may be reduced or avoided.

Various advantageous features may be obtained by utilizing batteries such as those shown and described herein. For example, use of such batteries may eliminate the need to utilize circuitry to disconnect batteries approaching near-zero voltage conditions. By not utilizing circuitry for this function, volume and cost reductions may be obtained.

According to an exemplary embodiment, lithium-ion batteries such as those described above may be used in conjunction with medical devices such as medical devices that may be implanted in the human body (referred to as “implantable medical devices” or “μIMD's”).

FIG. 6 illustrates a schematic view of a system 400 (e.g., an implantable medical device) implanted within a body or torso 432 of a patient 430. The system 400 includes a device 410 in the form of an implantable medical device that for purposes of illustration is shown as a defibrillator configured to provide a therapeutic high voltage (e.g., 700 volt) treatment for the patient 430.

The device 410 includes a container or housing 414 that is hermetically sealed and biologically inert according to an exemplary embodiment. The container may be made of a conductive material. One or more leads 416 electrically connect the device 410 and to the patient's heart 420 via a vein 422. Electrodes 417 are provided to sense cardiac activity and/or provide an electrical potential to the heart 420. At least a portion of the leads 416 (e.g., an end portion of the leads shown as exposed electrodes 417) may be provided adjacent or in contact with one or more of a ventricle and an atrium of the heart 420.

The device 410 includes a battery 440 provided therein to provide power for the device 410. According to another exemplary embodiment, the battery 440 may be provided external to the device or external to the patient 430 (e.g., to allow for removal and replacement and/or charging of the battery). The size and capacity of the battery 440 may be chosen based on a number of factors, including the amount of charge required for a given patient's physical or medical characteristics, the size or configuration of the device, and any of a variety of other factors. According to an exemplary embodiment, the battery is a 500 mAh battery. According to another exemplary embodiment, the battery is a 300 mAh battery. According to various other exemplary embodiments, the battery may have a capacity of between approximately 10 and 1000 mAh.

According to other exemplary embodiments, more than one battery may be provided to power the device 410. In such exemplary embodiments, the batteries may have the same capacity or one or more of the batteries may have a higher or lower capacity than the other battery or batteries. For example, according to an exemplary embodiment, one of the batteries may have a capacity of approximately 500 mAh while another of the batteries may have a capacity of approximately 75 mAh.

One or more capacitors (shown as capacitor bank 450) are provided in the device to store energy provided by the battery 440. For example, the system 410 may be configured such that when the device 410 determines that a therapeutic high-voltage treatment is required to establish a normal sinus rhythm for the heart 420, the capacitors in the capacitor bank 450 are charged to a predetermined charge level by the battery 440. Charge stored in the capacitors may then be discharged via the leads 416 to the heart 420. According to another exemplary embodiment, the capacitors may be charged prior to determination that a stimulating charge is required by the heart such that the capacitors may be discharged as needed.

According to another exemplary embodiment shown in FIG. 7, an implantable neurological stimulation device 500 (an implantable neuro stimulator or INS) may include a battery 502 such as those described above with respect to the various exemplary embodiments. Examples of other neuro stimulation products and related components are shown and described in a brochure titled “Implantable Neurostimulation Systems” available from Medtronic, Inc.

An INS generates one or more electrical stimulation signals that are used to influence the human nervous system or organs. Electrical contacts carried on the distal end of a lead are placed at the desired stimulation site such as the spine or brain and the proximal end of the lead is connected to the INS. The INS is then surgically implanted into an individual such as into a subcutaneous pocket in the abdomen, pectoral region, or upper buttocks area. A clinician programs the INS with a therapy using a programmer. The therapy configures parameters of the stimulation signal for the specific patient's therapy. An INS can be used to treat conditions such as pain, incontinence, movement disorders such as epilepsy and Parkinson's disease, and sleep apnea. Additional therapies appear promising to treat a variety of physiological, psychological, and emotional conditions. Before an INS is implanted to deliver a therapy, an external screener that replicates some or all of the INS functions is typically connected to the patient to evaluate the efficacy of the proposed therapy.

The INS 500 includes a lead extension 522 and a stimulation lead 524. The stimulation lead 524 is one or more insulated electrical conductors with a connector 532 on the proximal end and electrical contacts (not shown) on the distal end. Some stimulation leads are designed to be inserted into a patient percutaneously, such as the Model 3487A Pisces-Quad® lead available from Medtronic, Inc. of Minneapolis Minn., and stimulation some leads are designed to be surgically implanted, such as the Model 3998 Specify® lead also available from Medtronic.

Although the lead connector 532 can be connected directly to the INS 500 (e.g., at a point 536), typically the lead connector 532 is connected to a lead extension 522. The lead extension 522, such as a Model 7495 available from Medtronic, is then connected to the INS 500.

Implantation of an INS 520 typically begins with implantation of at least one stimulation lead 524, usually while the patient is under a local anesthetic. The stimulation lead 524 can either be percutaneously or surgically implanted. Once the stimulation lead 524 has been implanted and positioned, the stimulation lead's 524 distal end is typically anchored into position to minimize movement of the stimulation lead 524 after implantation. The stimulation lead's 524 proximal end can be configured to connect to a lead extension 522.

The INS 500 is programmed with a therapy and the therapy is often modified to optimize the therapy for the patient (i.e., the INS may be programmed with a plurality of programs or therapies such that an appropriate therapy may be administered in a given situation). In the event that the battery 502 requires recharging, an external lead (not shown) may be used to electrically couple the battery to a charging device or apparatus.

A physician programmer and a patient programmer (not shown) may also be provided to allow a physician or a patient to control the administration of various therapies. A physician programmer, also known as a console programmer, uses telemetry to communicate with the implanted INS 500, so a clinician can program and manage a patient's therapy stored in the INS 500, troubleshoot the patient's INS 500 system, and/or collect data. An example of a physician programmer is a Model 7432 Console Programmer available from Medtronic. A patient programmer also uses telemetry to communicate with the INS 500, so the patient can manage some aspects of her therapy as defined by the clinician. An example of a patient programmer is a Model 7434 Itrel® 3 EZ Patient Programmer available from Medtronic.

While the medical devices described herein (e.g., systems 400 and 500) are shown and described as a defibrillator and a neurological stimulation device, it should be appreciated that other types of implantable medical devices may be utilized according to other exemplary embodiments, such as pacemakers, cardioverters, cardiac contractility modulators, drug administering devices, diagnostic recorders, cochlear implants, and the like for alleviating the adverse effects of various health ailments. According to still other embodiments, non-implantable medical devices or other types of devices may utilize batteries as are shown and described in this disclosure.

It is also contemplated that the medical devices described herein may be charged or recharged when the medical device is implanted within a patient. That is, according to an exemplary embodiment, there is no need to disconnect or remove the medical device from the patient in order to charge or recharge the medical device. For example, transcutaneous energy transfer (TET) may be used, in which magnetic induction is used to deliver energy from outside the body to the implanted battery, without the need to make direct physical contact to the implanted battery, and without the need for any portion of the implant to protrude from the patient's skin. According to an exemplary embodiment, a connector may be provided external to the patient's body that may be electrically coupled to a charging device in order to charge or recharge the battery. According to other exemplary embodiments, medical devices may be provided that may require removal or detachment from the patient in order to charge or recharge the battery.

It should be understood that while the present disclosure describes the use of lithium-ion batteries with a variety of medical devices, such batteries may be used in a variety of other applications, including computers (e.g., laptop computers), phones (e.g., cellular, mobile, or cordless phones), automobiles, and any other device or application for which it may be advantageous to provide power in the form of a lithium-ion battery.

It is also important to note that the construction and arrangement of the lithium-ion battery as shown and described with respect to the various exemplary embodiments is illustrative only. Although only a few embodiments of the present inventions have been described in detail in this disclosure, those skilled in the art who review this disclosure will readily appreciate that many modifications are possible (e.g., variations in sizes, dimensions, structures, shapes and proportions of the various elements, values of parameters, mounting arrangements, use of materials, colors, orientations, etc.) without materially departing from the novel teachings and advantages of the subject matter recited in the claims. Accordingly, all such modifications are intended to be included within the scope of the present invention as defined in the appended claims. Other substitutions, modifications, changes and omissions may be made in the design, operating conditions and arrangement of the preferred and other exemplary embodiments without departing from the scope of the present invention as expressed in the appended claims. 

1. A medical device comprising: a rechargeable lithium-ion battery for providing power to the medical device, the lithium-ion battery comprising: a positive electrode comprising a current collector and a first active material; and a negative electrode comprising a current collector, a second active material, and a third active material; wherein the first active material, second active material, and third active material are configured to allow doping and undoping of lithium ions; and wherein the third active material exhibits charging and discharging capacity below a corrosion potential of the current collector of the negative electrode and above a decomposition potential of the first active material.
 2. The medical device of claim 1, wherein at least a portion of the medical device is configured for implantation into a body of a patient.
 3. The medical device of claim 2, wherein a portion of the medical device including the lithium-ion battery is implanted into the body of the patient, wherein the lithium-ion battery may be charged without removing the battery from the body of the patient.
 4. The medical device of claim 1, wherein the medical device comprises a neurological stimulation device.
 5. The medical device of claim 4, wherein the neurological stimulation device is configured to provide a therapeutic treatment to a patient by electrically stimulating a portion of at least one of a patient's brain and a patient's spine.
 6. The medical device of claim 5, wherein the neurological stimulation device is programmed to selectively provide a plurality of therapeutic treatments to a patient.
 7. The medical device of claim 1, wherein the medical device is selected from the group consisting of a cardiac defibrillator, a cardiac pacemaker, a cardiac contractility modulator, a cardioverter, a drug administration device, a cochlear implant, a hearing aid, a sensor, a telemetry device, and a diagnostic recorder.
 8. The medical device of claim 7, wherein the device is an implantable cardiac defibrillator for providing a therapeutic high voltage treatment to a patient.
 9. The medical device of claim 1, wherein the positive electrode and the negative electrode have zero voltage crossing potentials below the corrosion potential of the current collector of the negative electrode and above the decomposition potential of the first active material.
 10. The medical device of claim 1, wherein the first active material is a material selected from the group consisting of LiCoO₂, LiCo_(x)Ni_((1−x))O₂, LiNi_(x)Co_(y)Al_(z)O₂ and combinations thereof.
 11. The medical device of claim 10, wherein the current collector of the negative electrode comprises a material selected from the group consisting of copper, titanium, aluminum, and nickel.
 12. The medical device of claim 11, wherein the second active material comprises a carbonaceous material.
 13. The medical device of claim 12, wherein the third active material comprises a material selected from the group consisting of LiMn₂O₄, Li_(x)VO₂, LiM_(x)Mn_((2−x))O₄ (where M is a metal), and combinations thereof.
 14. The medical device of claim 12, wherein the third active material does not include lithium.
 15. The medical device of claim 14, wherein the third active material comprises V₆O₁₃.
 16. The medical device of claim 14, wherein the third active material comprises a material selected from the group consisting of V₂O₅, V₃O₈, MoO₃, TiS₂, WO₂, MoO₂, RuO₂, and combinations thereof.
 17. The medical device of claim 14, further comprising a quantity of lithium provided in electrical contact with the current collector of the negative electrode.
 18. The medical device of claim 17, wherein the quantity of lithium is configured to provide a lithium capacity for the negative electrode sufficient to at least compensate for irreversible loss of capacity of the negative electrode.
 19. The medical device of claim 11, wherein the second active material comprises a lithium titanate material.
 20. The medical device of claim 19, wherein the third active material comprises a material selected from the group consisting of LiMn₂O₄, Li_(x)VO₂, LiM_(x)Mn_((2−x))O₄ (where M is a metal), and combinations thereof.
 21. The medical device of claim 19, wherein the third active material does not include lithium.
 22. The medical device of claim 21, wherein the third active material comprises a material selected from the group consisting of V₂₀₅; V₆O₁₃, V₃O₈, MoO₃, TiS₂, WO₂, MoO₂, RuO₂, and combinations thereof.
 23. The medical device of claim 21, further comprising a quantity of lithium provided in electrical contact with the current collector of the negative electrode.
 24. The medical device of claim 23, wherein the quantity of lithium is configured to provide a lithium capacity for the negative electrode sufficient to at least compensate for irreversible loss of capacity of the negative electrode.
 25. The medical device of claim 1, further comprising a polymeric separator provided intermediate the positive electrode and the negative electrode.
 26. The medical device of claim 1, wherein the battery has a capacity between approximately 10 mAh and 1000 mAh.
 27. A device for providing a therapeutic treatment to a patient comprising: a rechargeable battery for providing power for the device, the battery comprising: a positive current collector; a negative current collector; an active material provided on the positive current collector; an active material layer provided on the negative current collector, the active material layer comprising a primary active material and a secondary active material, the secondary active material exhibiting charge and discharge capacity below a corrosion potential of the negative current collector, wherein the secondary active material does not include lithium, and a mass of lithium provided in electrical contact with a portion of the negative current collector.
 28. The device of claim 27, wherein at least a portion of the device is configured for implantation into a body of a patient and the lithium-ion battery may be charged without removing the battery from the body of the patient.
 29. The device of claim 27, wherein the device comprises a neurological stimulation device.
 30. The device of claim 27, wherein the device is selected from the group consisting of a cardiac defibrillator, a cardiac pacemaker, a cardiac contractility modulator, a cardioverter, a drug administration device, a cochlear implant, a hearing aid, a sensor, a telemetry device, and a diagnostic recorder.
 31. The device of claim 30, wherein the device is an implantable cardiac defibrillator for providing a therapeutic high voltage treatment to a patient.
 32. The device of claim 27, wherein the mass of lithium provides a lithium capacity sufficient to at least compensate for irreversible loss of capacity of the battery.
 33. The device of claim 32, wherein the mass of lithium provides a lithium capacity equal to the sum of the irreversible loss of capacity of the battery and the capacity of the secondary active material.
 34. The device of claim 27, wherein the zero voltage crossing potential of the battery is below the corrosion potential of the negative current collector and above the decomposition potential of the active material provided on the positive current collector.
 35. The device of claim 27, wherein the active material provided on the positive current collector is a material selected from the group consisting of LiCoO₂, LiCo_(x)Ni_((1−x))O₂, and LiNi_(x)Co_(y)Al_(z)O₂.
 36. The device of claim 35, wherein the primary active material comprises a carbonaceous material.
 37. The device of Claim 36, wherein the secondary active material comprises a material selected from the group consisting of V₂O₅, V₆O₁₃, V₃O₈, MoO₃, TiS₂, WO₂, MoO₂, RuO₂, and combinations thereof.
 38. The device of claim 35, wherein the primary active material comprises a lithium titanate material.
 39. The device of claim 38, wherein the secondary active material comprises a material selected from the group consisting of V₂O₅, V₆O₁₃, V₃O₈, MoO₃, TiS₂, WO₂, MoO₂, RuO₂, and combinations thereof.
 40. The device of claim 27, wherein the battery has a capacity between approximately 10 mAh and 1000 mAh.
 41. A system for providing a medical treatment to a patient comprising: a lithium-ion battery configured to provide power to the system and capable of being charged and discharged, the lithium-ion battery comprising: a positive electrode comprising a positive current collector and an active material provided on at least one side of the positive current collector; a negative electrode having a negative current collector and a primary active material and an auxiliary active material provided on at least one side of the negative current collector; wherein the auxiliary active material comprises lithium and provides charging and discharging capacity for the positive electrode below a corrosion potential of the negative current collector and above a decomposition potential of the active material provided on the positive current collector.
 42. The system of claim 41, wherein at least a portion of the medical device is configured for implantation into a body of a patient.
 43. The system of claim 42, wherein the lithium-ion battery may be charged without removing the battery from the body of the patient.
 44. The system of claim 41, wherein the system comprises a neurological stimulation device.
 45. The system of claim 41, wherein the system comprises a device selected from the group consisting of a cardiac defibrillator, a cardiac pacemaker, a cardiac contractility modulator, a cardioverter, a drug administration device, a cochlear implant, a hearing aid, a sensor, a telemetry device, and a diagnostic recorder.
 46. The system of claim 41, wherein the active material provided on the positive current collector comprises LiCoO₂.
 47. The system of claim 46, wherein the primary active material provided on the negative current collector comprises a carbonaceous material.
 48. The system of claim 47, wherein the auxiliary active material comprises a material selected from the group consisting of LiMn₂O₄, Li_(x)VO₂, LiM_(x)Mn_((2−x))O₄ (where M is a metal), and combinations thereof.
 49. The system of claim 46, wherein the primary active material provided on the negative current collector comprises Li₄Ti₅O₁₂.
 50. The system of claim 49, wherein the auxiliary active material comprises a material selected from the group consisting of LiMn₂O₄, Li_(x)VO₂, LiM_(x)Mn_((2−x))O₄ (where M is a metal), and combinations thereof.
 51. The system of claim 41, wherein the lithium-ion battery has a capacity between approximately 10 mAh and 1000 mAh.
 52. The system of claim 41, wherein the corrosion potential of the negative current collector is approximately 3.5 volts.
 53. The system of claim 41, wherein the negative current collector comprises at least one of copper and titanium.
 54. A method of treating a medical condition of a patient comprising: providing at least a portion of a medical device in contact with the patient; and providing a treatment to the patient utilizing the medical device; wherein the medical device receives power from a battery comprising: a positive electrode comprising a current collector and a first active material; and a negative electrode comprising a current collector, a second active material, and a third active material; wherein the first active material, second active material, and third active material are configured to allow doping and undoping of lithium ions; and wherein the third active material exhibits charging and discharging capacity below a corrosion potential of the current collector of the negative electrode and above a decomposition potential of the first active material.
 55. The method of claim 54 wherein the step of providing at least a portion of a medical device in contact with the patient comprises implanting at least a portion of the medical device in the patient.
 56. The method of claim 55, further comprising charging the battery without removing the implanted portion of the medical device from the patient.
 57. The method of claim 54, wherein the method comprises a neurological stimulation device.
 58. The method of claim 57, wherein the step of providing a treatment to the patient comprises electrically stimulating a portion of at least one of a patient's brain and a patient's spine.
 59. The method of claim 58, wherein the step of providing a treatment to the patient comprises selectively providing a plurality of therapeutic treatments to a patient.
 60. The method of claim 54, wherein the method is selected from the group consisting of a cardiac defibrillator, a cardiac pacemaker, a cardiac contractility modulator, a cardioverter, a drug administration device, a cochlear implant, a hearing aid, a sensor, a telemetry device, and, a diagnostic recorder.
 61. The method of claim 60, wherein the method is an implantable cardiac defibrillator for providing a therapeutic high voltage treatment to a patient.
 62. The method of claim 54, wherein the first active material is a material selected from the group consisting of LiCoO₂, LiCo_(x)Ni_((1−x))O₂, and LiNi_(x)Co_(y)Al_(x)O₂.
 63. The method of claim 62, wherein the current collector of the negative electrode comprises a material selected from the group consisting of copper and titanium.
 64. The method of claim 63, wherein the second active material comprises a carbonaceous material or a lithium titanate material.
 65. The method of claim 64, wherein the third active material comprises a material selected from the group consisting of LiMn₂O₄, Li_(x)VO₂, LiM_(x)Mn_((2−x))O₄ (where M is a metal), and combinations thereof.
 66. The method of claim 64, wherein the third active material does not include lithium.
 67. The method of claim 66, wherein the third active material comprises a material selected from the group consisting of V₂O₅, V₆O₁₃, V₃O₈, MoO₃, TiS₂, WO₂, MoO₂, RuO₂, and combinations thereof.
 68. The method of claim 66, further comprising a patch comprising lithium provided in electrical contact with the current collector of the negative electrode.
 69. The method of claim 68, wherein the patch is configured to provide a lithium capacity for the negative electrode sufficient to at least compensate for irreversible loss of capacity of the negative electrode.
 70. The method of claim 64, wherein the battery has a capacity between approximately 10 mAh and 1000 mAh. 